Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 2/2015

01-02-2015 | Original

Prognosis of neutropenic patients admitted to the intensive care unit

Authors: D. Mokart, M. Darmon, M. Resche-Rigon, V. Lemiale, F. Pène, J. Mayaux, A. Rabbat, A. Kouatchet, F. Vincent, M. Nyunga, F. Bruneel, C. Lebert, P. Perez, A. Renault, R. Hamidfar, M. Jourdain, A.-P. Meert, D. Benoit, S. Chevret, E. Azoulay

Published in: Intensive Care Medicine | Issue 2/2015

Login to get access

Abstract

Purpose

The prognosis of critically ill cancer patients has improved recently. Controversies remain as regard to the specific prognosis impact of neutropenia in critically ill cancer patients. The primary objective of this study was to assess hospital outcome of critically ill neutropenic cancer patients admitted into the ICU. The secondary objective was to assess risk factors for unfavorable outcome in this population of patients and specific impact of neutropenia.

Methods

We performed a post hoc analysis of a prospectively collected database. The study was carried out in 17 university or university-affiliated centers in France and Belgium. Neutropenia was defined as a neutrophil count lower than 500/mm3.

Results

Among the 1,011 patients admitted into the ICU during the study period 289 were neutropenic at the time of admission. Overall, 131 patients died during their hospital stay (hospital mortality 45.3 %). Four variables were associated with a poor outcome, namely allogeneic transplantation (OR 3.83; 95 % CI 1.75–8.35), need for mechanical ventilation (MV) (OR 6.57; 95 % CI 3.51–12.32), microbiological documentation (OR 2.33; CI 1.27–4.26), and need for renal replacement therapy (OR 2.77; 95 % CI 1.34–5.74). Two variables were associated with hospital survival, namely age younger than 70 (OR 0.22; 95 % CI 0.1–0.52) and neutropenic enterocolitis (OR 0.37; 95 % CI 0.15–0.9). A case–control analysis was also performed with patients of the initial database; after adjustment, neutropenia was not associated with hospital mortality (OR 1.27; 95 % CI 0.86–1.89).

Conclusion

Hospital survival was closely associated with younger age and neutropenic enterocolitis. Conversely, need for conventional MV, for renal replacement therapy, and allogeneic hematopoietic stem cell transplantation (HSCT) were associated with poor outcome.
Appendix
Available only for authorised users
Literature
1.
Recher C, Coiffier B, Haioun C, Molina TJ, Ferme C, Casasnovas O et al (2011) Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. Lancet 378:1858–1867PubMedCrossRef
2.
Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE et al (2012) Clinical cancer advances 2011: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 30:88–109PubMedCrossRef
3.
Zuber B, Tran TC, Aegerter P, Grimaldi D, Charpentier J, Guidet B et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62PubMedCrossRef
4.
Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F et al (2008) Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 36:100–107PubMedCrossRef
5.
Vincent F, Hospital MA, Lemiale V, Bruneel F, Darmon M, Gonzalez F et al (2012) Therapeutic of respiratory manifestations at the early phase of acute myeloid leukaemia. Rev Mal Respir 29:743–755PubMedCrossRef
6.
Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49PubMedCrossRef
7.
Mokart D, van CT, Lambert J, Textoris J, Brun JP, Sannini A et al (2012) Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J 40:169–176PubMedCrossRef
8.
Mokart D, Azoulay E, Schnell D, Bourmaud A, Kouatchet A, Pene F et al (2013) Acute respiratory failure in neutropenic patients is associated with a high post-ICU mortality. Minerva Anestesiol 79:1156–1163PubMed
9.
10.
Maschmeyer G, Carratala J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C et al (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26:21–33
11.
Maschmeyer G, Beinert T, Buchheidt D, Cornely OA, Einsele H, Heinz W et al (2009) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 45:2462–2472PubMedCrossRef
12.
Mokart D, Textoris J, Ettori F, Chetaille B, Blache JL (2011) Acute respiratory distress syndrome (ARDS) in neutropenic patients. In: Azoulay E (ed) Pulmonary involvement in patients with hematological malignancies. Springer, Berlin Heidelberg, pp 477–490
13.
14.
Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 31:2810–2818PubMedCrossRef
15.
Vincent JL, de MA, Cantraine F, Moreno R, Takala J, Suter PM et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:1793–1800PubMedCrossRef
16.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef
17.
Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG Jr (1987) Morbidity during hospitalization: can we predict it? J Chronic Dis 40:705–712PubMedCrossRef
18.
Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A et al (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046PubMedCrossRef
19.
Mourad M, Chow-Chine L, Faucher M, Sannini A, Brun JP, de Guibert JM et al (2014) Early diastolic dysfunction is associated with intensive care unit mortality in cancer patients presenting with septic shock. Br J Anaesth 112:102–109PubMedCrossRef
20.
Mourad M, Chow-Chine L, Faucher M, Sannini A, Brun JP, de Guibert JM et al (2013) Early diastolic dysfunction is associated with intensive care unit mortality in cancer patients presenting with septic shock. Br J Anaesth 112(1):102–109PubMedCrossRef
21.
De PB, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821CrossRef
22.
23.
Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Le Gall JR et al (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 28:1775–1780PubMedCrossRef
24.
Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B et al (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 24:643–649PubMedCrossRef
25.
Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370CrossRef
26.
Buchner T, Berdel WE, Wormann B, Schoch C, Haferlach T, Schnittger S et al (2005) Treatment of older patients with AML. Crit Rev Oncol Hematol 56:247–259PubMedCrossRef
27.
Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235–242PubMedCrossRef
28.
29.
Rhee CK, Kang JY, Kim YH, Kim JW, Yoon HK, Kim SC et al (2009) Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies. Crit Care 13:R173PubMedCentralPubMedCrossRef
30.
Karlin L, Darmon M, Thiery G, Ciroldi M, de Miranda S, Lefebvre A et al (2005) Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant 36:245–250PubMedCrossRef
31.
Berghmans T, Paesmans M, Lafitte JJ, Mascaux C, Meert AP, Jacquy C et al (2002) Therapeutic use of granulocyte and granulocyte–macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis. Support Care Cancer 10:181–188PubMedCrossRef
32.
Hohenberger P, Buchheidt D (2005) Surgical interventions in patients with hematologic malignancies. Crit Rev Oncol Hematol 55:83–91PubMedCrossRef
33.
Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV et al (2008) Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg 248:104–109PubMedCrossRef
34.
Cronin CG, O’Connor M, Lohan DG, Keane M, Roche C, Bruzzi JF et al (2009) Imaging of the gastrointestinal complications of systemic chemotherapy. Clin Radiol 64:724–733PubMedCrossRef
35.
Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMedCrossRef
36.
Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J et al (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:2294–2303PubMedCrossRef
37.
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:427–431PubMedCrossRef
38.
Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 8:e55870PubMedCentralPubMedCrossRef
39.
Munker R, Hill U, Jehn U, Kolb HJ, Schalhorn A (1998) Renal complications in acute leukemias. Haematologica 83:416–421PubMed
Metadata
Title
Prognosis of neutropenic patients admitted to the intensive care unit
Authors
D. Mokart
M. Darmon
M. Resche-Rigon
V. Lemiale
F. Pène
J. Mayaux
A. Rabbat
A. Kouatchet
F. Vincent
M. Nyunga
F. Bruneel
C. Lebert
P. Perez
A. Renault
R. Hamidfar
M. Jourdain
A.-P. Meert
D. Benoit
S. Chevret
E. Azoulay
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 2/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3615-y

Other articles of this Issue 2/2015

Intensive Care Medicine 2/2015 Go to the issue

Erratum

Erratum to: Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management

Editorial

Comparing intensive care units by size or level

Understanding the Disease

Understanding nurse–physician conflicts in the ICU

Original

Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage

Imaging in Intensive Care Medicine

Lemierre’s syndrome: when a contralateral thrombosis stirs the debate

Editorial

Energy deficit is clinically relevant for critically ill patients: yes